WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3.98 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr | ₹44 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3.98 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹44 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3.98 Cr | -79.91 | |
Mar2023 | ₹20 Cr | -51.15 | |
Mar2022 | ₹41 Cr | 142.91 | |
Mar2021 | ₹17 Cr | -62.20 | |
Mar2020 | ₹44 Cr | - |
Compare Cash Flow from Operating Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹712.6 Cr | -4% | -21.5% | 37.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -4% |
-21.5% |
37.8% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses